4.6 Article

Akt2 influences glycogen synthase activity in human skeletal muscle through regulation of NH2-terminal (sites 2+2a) phosphorylation

Journal

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpendo.00494.2012

Keywords

glycogen synthesis; insulin signaling; muscle; phosphatidylinositol 3-kinase/protein kinase B; diabetes

Funding

  1. Danish Agency for Science Technology and Innovation
  2. Danish Medical Research Council
  3. Danish Strategic Research Council
  4. Novo Nordisk Foundation
  5. Danish Diabetes Association
  6. Lundbeck Foundation
  7. UNIK Project: Food, Fitness, & Pharma for Health and Disease
  8. Danish Ministry of Science, Technology, and Innovation
  9. integrated 6th Frame Work EU project (EXGENESIS) from the European Union [LSHM-CT-2004-005272]
  10. National Institutes of Health [R01-AR-42238]

Ask authors/readers for more resources

Friedrichsen M, Birk JB, Richter EA, Ribel-Madsen R, Pehmoller C, Hansen BF, Beck-Nielsen H, Hirshman MF, Goodyear LJ, Vaag A, Poulsen P, Wojtaszewski JF. Akt2 influences glycogen synthase activity in human skeletal muscle through regulation of NH2-terminal (sites 2 + 2a) phosphorylation. Am J Physiol Endocrinol Metab 67: E631-E639, 2013. First published January 15, 2012; doi:10.1152/ajpendo.00494.2012.-Type 2 diabetes is characterized by reduced muscle glycogen synthesis. The key enzyme in this process, glycogen synthase (GS), is activated via proximal insulin signaling, but the exact molecular events remain unknown. Previously, we demonstrated that phosphorylation of Thr(308) on Akt (p-Akt-Thr(308)), Akt2 activity, and GS activity in muscle were positively associated with insulin sensitivity. Here, in the same study population, we determined the influence of several upstream elements in the canonical PI3K signaling on muscle GS activation. One-hundred eighty-one nondiabetic twins were examined with the euglycemic hyperinsulinemic clamp combined with excision of muscle biopsies. Insulin signaling was evaluated at the levels of the insulin receptor, IRS-1-associated PI3K (IRS-1-PI3K), Akt, and GS employing activity assays and phosphospecific Western blotting. The insulin-stimulated GS activity was positively associated with p-Akt-Thr(308) (P = 0.01) and Akt2 activity (P = 0.04) but not p-Akt-Ser(473) or IRS-1-PI3K activity. Furthermore, p-Akt-Thr(308) and Akt2 activity were negatively associated with NH2-terminal GS phosphorylation (P = 0.001 for both), which in turn was negatively associated with insulin-stimulated GS activity (P < 0.001). We found no association between COOH-terminal GS phosphorylation and Akt or GS activity. Employing whole body Akt2-knockout mice, we validated the necessity for Akt2 in insulin-mediated GS activation. However, since insulin did not affect NH2-terminal phosphorylation in mice, we could not use this model to validate the observed association between GS NH2-terminal phosphorylation and Akt activity in humans. In conclusion, our study suggests that although COOH-terminal dephosphorylation is likely necessary for GS activation, Akt2-dependent NH2-terminal dephosphorylation may be the site for fine-tuning insulin-mediated GS activation in humans.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available